Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
about
Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.Repurposing metformin for the prevention of cancer and cancer recurrence.Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.Metformin: a review of its potential indications.Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic FactorsmiR-33a is a tumor suppressor microRNA that is decreased in prostate cancer.Metformin: A Bridge between Diabetes and Prostate Cancer.Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.Drug repurposing for the treatment of glioblastoma multiforme.Fasting Blood Glucose Level in Locally Advanced Non-Small Cell Lung Cancer: a New Prognostic Factor?The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia.Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors.Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell ViabilityBiguanides enhance antifungal activity against Candida glabrataPleiotropic Effects of Metformin on Cancer
P2860
Q36194195-1DE3AC5F-75E3-4F38-848F-4EC6E3E1A380Q37706025-E65FD84E-3110-4EE6-A86E-5FBBC49D7377Q38668187-9BF05DC1-A5CB-4270-8E47-F8021F2CE475Q38674812-C762602E-5B7A-415F-BAA3-56772F51B14CQ38695734-734782EB-42BB-4406-934C-AE2F24FD6E84Q39391684-0320A1A6-20C0-40D3-A15B-5D6C583F4272Q41036251-8FA1F30A-F577-4182-BECC-4126F03C19CCQ41396184-ACEB61BD-4D07-4B07-9DBE-9B5F3F77C55EQ41545473-55DCAD98-7F2E-4C34-92C0-B33B969F47E4Q41673272-44EC712D-96B8-4C1E-9A16-342C9DE6D811Q41694147-3D8F27EE-6718-42A6-8448-EAD32329B393Q42700292-A3E9ECF0-F2F2-45C2-8CAA-BDC3475C94D9Q45783993-75797E26-AE19-432B-AE73-BB3D1CE415E3Q47129780-3E4D2921-621C-40CA-8C0B-846FFB50CB44Q47767194-3F461CBB-12B7-4293-8494-7560762F4FBBQ47948290-B8D97575-0562-42BE-861B-B666B4AA7B3CQ48229894-C6B31F32-648D-418F-AC77-FA695B5BF026Q50050991-0874C71F-E3D8-4D80-9356-545AAC83A0D4Q50206074-89C102F3-8D8C-4CD2-8F5B-F6A2772DCB73Q51244733-070979D5-2C8F-455D-9DAD-FFD099EF9D4DQ52331264-DD3E55E3-B688-463F-8B8C-9D2E01311EB1Q52593454-771FC17D-E5C3-45FE-A4A4-CCDA074E1702Q58728819-B1CC8CC1-A0F7-4FDF-8C49-A61317BDBFE2Q58806129-4BE19011-2133-42BB-B8B9-D293E1D70F94Q59138314-8D3563F8-85CC-4FAF-9604-9319B8CB27DF
P2860
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@ast
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@en
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@nl
type
label
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@ast
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@en
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@nl
prefLabel
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@ast
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@en
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDW410
P407
P5008
P577
2016-09-28T00:00:00Z